Joy Laoun
News Editor, Vestbee
The Series B round came from the Cystic Fibrosis Foundation and the German Federal Agency for Breakthrough Innovation (SPRIN-D).
The $2.5 million pre-seed round saw support from Frontline Ventures and BrightCap Ventures.
The fresh investment was supported by BlackPeak Capital.
The Series B round came from the Cystic Fibrosis Foundation and the German Federal Agency for Breakthrough Innovation (SPRIN-D).
The $2.5 million pre-seed round saw support from Frontline Ventures and BrightCap Ventures.
The fresh investment was supported by BlackPeak Capital.